Five-Year Registration Validity and Renewal in Argentina
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Argentina grants medical device registrations a validity of 5 years, and every registration can be renewed for an equal period — a further 5 years. The renewal procedure is known locally as revalidación. As for when the renewal must be filed, GMC 25/21 does not fix a specific date at the regional level; it defers the timing to the deadlines established under each member state’s national health regulations. For Argentina, the practical estimate is to submit the renewal 90 days before expiry, because the official Argentine texts do not hard-code a specific number of days. That 90-day mark is therefore an internal scheduling rule, not a statutory deadline, and prudent teams start even earlier.
Two key rules define the renewal regime. First, submitting a renewal application does not interrupt commercialization: while the renewal is under review, the product may continue to be sold. This differs from the practice in some other Latin American markets, where sales must stop while the renewal is being examined. Second, if a registration is not renewed before it lapses, the registration becomes invalid and the product must be re-registered as a new product; in the IVD field, Disposición 2198/2022 states this requirement expressly. For products that the company no longer markets, the correct move is to apply proactively for cancellation (cancelación) instead of leaving the certificate to lapse and accumulate obligations.
2. Legal basis
| Regulation | Reference number | Publication date | Relevant provisions |
|---|---|---|---|
| MERCOSUR technical regulation for medical device registration | GMC/RES 25/21 | October 13, 2021 | Validity and renewal provisions (timing deferred to national health regulations) |
| IVD registration procedure | Disposición ANMAT 2198/2022 | 2022 | Provision requiring re-registration as a new product after a lapsed renewal |
| National implementation instrument | Disposición ANMAT 64/2025 | Published January 13, 2025 in the Official Gazette | Registration validity provisions |
| RPPTM registry annual maintenance fee | Disposición ANMAT 5634/2024 | 2024 | Annual maintenance fee provisions |
3. Expert insights
Insight 1: The 90-day mark is a practical estimate, not a statutory number. GMC 25/21 hands the power to set renewal timing to the health regulations of each member state, and the Argentine official texts have not fixed a concrete number of days. The 90-day figure circulated in practice is therefore a safety line that companies build into their internal project schedules, not a legal cut-off that ANMAT enforces by name. In actual operation it is advisable to start earlier still, because document updates, translations, and internal approvals all consume calendar time, and a missed renewal window cannot be recovered administratively once the certificate has lapsed.
Insight 2: Renewal without interruption of commercialization is a relatively friendly feature of the Argentine system. It stands in clear contrast to the rules of some markets that suspend sales while a renewal is under review. But the same feature carries a side effect: because the product can legally keep selling during the review, companies tend to underestimate the urgency of renewal, reasoning that sales can continue anyway, and then drift past the expiry date. Once the certificate lapses, the friendly feature disappears entirely, and the full cost of a new registration — new fees, new review, new timeline — becomes unavoidable.
Insight 3: The annual maintenance fee and the 5-year renewal are two independent actions. Beyond the once-every-5-years renewal, the registration holder must also pay the annual RPPTM registry maintenance fee under Disposición 5634/2024. Missing either one puts the registration into an abnormal status, so a compliance calendar that watches only the 5-year cycle is incomplete. The two obligations run on different clocks, have different amounts, and are collected under different provisions, which is precisely why they must be tracked as separate line items in the annual compliance plan rather than bundled into a single renewal reminder.
Taken together, these rules mean that renewal in Argentina is less about surviving a sales blackout and more about disciplined scheduling: the certificate keeps its commercial value only if the holder files on time every 5 years and pays the annual fee every year. A company that treats the two obligations as one calendar entry will eventually discover the gap the hard way, when the registration status turns abnormal or the certificate lapses without warning.
4. Practical recommendations
- Adopt an internal rule of starting 12 months before expiry. Begin preparing the renewal dossier 12 months ahead of the expiry date — updating the technical documentation, refreshing GMP status, and compiling the risk management report — and file the formal renewal 90 days before expiry under the practical estimate.
- Prepare renewal materials to a new-product standard. Four items form the core: the updated technical documentation, the ISO 13485 certificate, the risk management report, and post-market vigilance data. Compile all four at the quality level expected of a new submission rather than treating renewal as a light-touch formality.
- Keep the annual maintenance fee and the renewal on separate calendars. Set independent reminders for the two actions so that a missed annual fee does not put the registration into an abnormal status in a year when no renewal is even due.
- Cancel registrations for products no longer marketed. Filing a proactive cancellation (cancelación) avoids unnecessary annual maintenance fees and standing compliance obligations on certificates that no longer generate revenue.
5. Verification checklist
- □ Confirmed that the registration is valid for 5 years and renewable for an equal period
- □ Renewal dossier preparation started 12 months before expiry
- □ Renewal application scheduled for filing 90 days before expiry (practical estimate)
- □ Updated technical documentation, ISO 13485 certificate, and risk management report are complete
- □ Post-market vigilance data organized and usable as renewal support material
- □ A separate reminder is in place for the annual maintenance fee payment (5634/2024)
- □ Proactive cancellation is planned for products no longer marketed
Regulatory information verified as of October 29, 2026.
In Argentina, GRZAN operates a wholly-owned subsidiary that can serve as the registration holder and importer for foreign manufacturers, directly handling classification determination, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and label localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance, and 5-year renewal planning.
The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience and tracks the dynamics of regulatory authorities across countries on an ongoing basis. All external content follows the drafting standard of conclusions first, traceable bases, and verifiable figures. For an Argentina or MERCOSUR market access plan tailored to a specific product, contact the GRZAN regulatory team at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us